Clavis Pharma

Related by string. * Clavier . clavier . CLAVIS : Well Tempered Clavier . Jeff Clavier . Natalia Clavier . ticker CLAVIS . Clavis Walden . Clavis / pharmas . Pharmas . PHARMA . pharma : Omega Pharma Lotto . pharma biotech . Sun Pharma . Elder Pharma . Omega Pharma . Royalty Pharma . Azur Pharma BioSante licensee . pharma ceutical * Clavis Pharma ASA OSE . Clavis Pharma ASA . concerning Clavis Pharma *

Related by context. All words. (Click for frequent words.) 72 Clavis Pharma ASA 72 Santhera 72 Photocure 71 Biovitrum 71 Active Biotech 71 Karo Bio 71 WILEX 70 Swedish Orphan Biovitrum 70 Orexo 70 Biotec Pharmacon 68 Biotie 68 immatics 68 PAION 67 Kiadis Pharma 67 Algeta 67 CLAVIS 67 Pharmexa 67 HuMax CD4 67 Helsinn Healthcare 67 Æterna Zentaris 67 Symphogen 67 Vaccinex 67 Clovis Oncology 66 Chemokine Therapeutics 66 Intravenous CP 66 PregLem 66 Fresenius Biotech 66 Proxinium TM 66 TOPIGEN 66 Ziopharm 66 Annamycin 66 Allovectin 7 66 PhotoCure 66 Harbor BioSciences 66 SYGNIS 66 TopoTarget 66 Aegera 66 BioInvent 66 Manja Bouman CEO 66 NeuroSearch 66 Personalized Immunotherapy 66 RhuDex ® 66 Bicifadine 65 Biolipox 65 YONDELIS 65 Tripep 65 Phase Ib study 65 BioTie 65 PhotoCure ASA 65 ATL# [001] 65 Loramyc R 65 Ablynx 65 elotuzumab 65 Affitech 65 Chemokine 65 CR# vcMMAE 65 ELACYT 65 ThromboGenics 65 Affitech AS 65 Archexin 65 BioNumerik 65 AEterna 65 Alligator Bioscience AB 65 Active Biotech AB 65 Pharmion Corporation 65 atacicept 65 Syndax 65 Vernalis plc 65 Nitec 65 INCB# [001] 65 Algeta ASA OSE ALGETA 64 Ocrelizumab 64 Opexa 64 Axentis Pharma 64 IMA# 64 Elisabeth Lindner CEO 64 Allovectin 7 R 64 Phase IIb trials 64 torezolid phosphate 64 Addex Pharmaceuticals 64 Troxatyl 64 Mersana 64 phase IIa clinical 64 Diamyd Medical 64 phase IIb clinical 64 SCOLR Pharma 64 Hana Biosciences 64 Helsinn 64 Scancell 64 Pharmalink AB 64 Aviptadil 64 NOXXON 64 Oasmia 64 registrational 64 elacytarabine 64 OvaRex ® MAb 64 JAK inhibitor 64 Omthera 64 Inflazyme 64 ChemoCentryx 64 Evoltra TM 64 AB OMXS BINV 64 Nanobody 64 Medivir AB 64 Prosensa 64 EndoTAG TM -1 64 Cerimon 64 Calixa 64 Plicera 64 Molecular Insight 64 mertansine 64 Panzem R 64 Vitaflo Scandinavia AB 64 dirucotide 64 Traficet EN 64 Clavis Pharma ASA OSE 64 NovaDel 64 Diamyd 63 Biotie Therapies Corp. 63 KYTHERA 63 Amrubicin 63 Timo Veromaa President 63 MDxHealth 63 Meda AB 63 TRO# 63 ProFibrix 63 Bezielle 63 Virulizin R 63 PRT# 63 Syntonix 63 Virulizin ® 63 Relypsa 63 RhuDex 63 AEterna Zentaris 63 oral ridaforolimus 63 Factor VIIa 63 ularitide 63 OncoGel 63 Sunesis Pharmaceuticals 63 Viralytics 63 LifeCycle Pharma 63 VentiRx 63 FOLOTYN ® 63 PDE4 inhibitor 63 Aegerion 63 Desmoteplase 63 anticancer compound 63 GammaCan 63 H3 Pharma 63 Sym# 63 seliciclib CYC# 63 Arno Therapeutics 63 Apricus Bio 63 Teysuno 63 Solasia 63 Guanilib 63 Summary Genmab 63 entinostat 63 LHRH antagonist 63 EndoTAG 63 HQK 63 EnVivo 63 JAK1 63 Resverlogix 63 Proteo 63 alvespimycin 63 Hybridon 63 tanespimycin 63 EnzymeRx 63 eniluracil 63 Genitope Corporation 63 AQ4N 62 EOquin TM 62 tiapamil 62 depsipeptide 62 Corautus 62 CeNeS 62 Alzhemed TM 62 Pirfenidone 62 Fibrillex TM 62 Cabrellis 62 Zenvia ™ 62 Apitope 62 HuMax EGFr 62 Azedra TM 62 Mpex 62 Vion Pharmaceuticals 62 Spiro Rombotis President 62 lixivaptan 62 PrevOnco 62 HuMax CD# 62 Excaliard 62 Myriad Pharmaceuticals 62 Orexo AB 62 InNexus Biotechnology 62 romidepsin 62 Myocet 62 BioGeneriX 62 methylnaltrexone 62 Icatibant 62 InNexus 62 fipamezole 62 ATL/TV# 62 drug ISA# 62 QuatRx 62 Sirona Biochem 62 Lpath 62 PsychoGenics 62 ofatumumab HuMax CD# 62 Celator 62 OncoGenex Pharmaceuticals 62 Phase 2b trial 62 thymalfasin 62 GW# [003] 62 Xanafide 62 IAP inhibitor 62 LibiGel ® 62 Euroscreen 62 Kenta Biotech 62 Increlex TM 62 radiation sensitizer 62 MAGE A3 ASCI 62 ProLindac TM 62 Urocidin 62 Aegera Therapeutics 62 4SC AG 62 CoTherix 62 BioAlliance Pharma 62 rhMBL 62 phase IIb trial 62 PREOS R 62 Nanobody ® 62 zanolimumab 62 Phase 1b clinical trials 62 Agennix 62 Multiferon 62 BioAlliance 62 Tezampanel 62 Dynogen 62 MOZOBIL 62 Trophos 62 Preotact 62 Solazed 62 pradefovir 62 Ambrilia Biopharma 62 TPI ASM8 62 PHX# 62 ofatumumab 62 DXL# 62 TSX VENTURE URO 62 EFAPROXYN 62 Morten Jurs 62 EOquin 62 PGL# 62 SNT MC# 62 Jerini 62 Enobia 62 Pronova BioPharma 62 personalized immunotherapy 62 #D#C# 62 Navamedic 62 Thallion 62 PCI Biotech 62 Akela Pharma 62 Tranzyme 62 VitiGam 62 obatoclax 62 Metabolex 62 AMEX ONI 62 targeted radiotherapeutic 62 ThermoDox R 62 Algeta ASA 62 Allovectin 7 ® 62 AltaRex 62 Isotechnika 62 Modrenal R 62 Chrysalin 62 AZILECT R 62 Aeterna Zentaris 62 elbion 62 Micromet 62 Ceplene histamine dihydrochloride 62 AIM SLN Silence 62 Adherex 62 LEUKINE 62 Loramyc ® 62 Aflibercept 62 Revotar 62 Ophthotech 62 Kepivance 62 Anders Lonner 62 Evoltra 61 TG# [001] 61 CytoFab 61 NovImmune 61 TBC# 61 Lupuzor 61 IL# PE#QQR 61 Lappland Goldminers 61 Cellegesic 61 Campath ® 61 Stressgen 61 SinuNase ™ 61 Epitomics 61 Myrexis 61 vidofludimus 61 Diamyd ® 61 Addex Pharmaceuticals SWISS ADXN 61 AFFiRiS 61 NASDAQ OGXI 61 DiaGenic 61 Cetrorelix 61 Loramyc 61 Azedra 61 Transcept Pharmaceuticals 61 Loramyc ™ 61 MediGene 61 HELSINN 61 Tomas Leanderson 61 Ceflatonin 61 Meda STO MEDAA 61 Cloretazine ® 61 PROSTVAC TM 61 PLK1 SNALP 61 Idera Pharmaceuticals 61 Ascenta Therapeutics 61 mitogen activated ERK kinase 61 Genasense ® 61 Poniard Pharmaceuticals 61 bardoxolone 61 Onalta 61 Catena ® 61 Atiprimod 61 PREOS 61 IAP inhibitors 61 tranilast 61 Sopherion 61 GLPG# 61 IRX 2 61 registrational trial 61 CDP# 61 Glufosfamide 61 Ceregene 61 Cx# [002] 61 Ambrisentan 61 Addex Pharmaceuticals Ltd. 61 FoldRx 61 PXD# 61 XTLbio 61 AlphaRx 61 Igeneon 61 RIGScan CR 61 Onconase 61 eprotirome 61 Phase IIIb clinical 61 Phase Ib 61 OMP designation 61 AVAX 61 metaglidasen 61 HuLuc# 61 phase IIb 61 HepaSphere 61 Panzem R NCD 61 AEG# 61 MacroChem 61 UPLYSO 61 GED aPC 61 Genetronics 61 tosedostat 61 OncoGenex Pharmaceuticals Inc. 61 Auxilium Pharma 61 XmAb# 61 glucokinase activator 61 TRACON Pharmaceuticals 61 Phase #/#a 61 Atugen 61 Martin Nicklasson 61 Daclizumab 61 IIa trial 61 Galapagos NV Euronext GLPG 61 Daniel Junius 61 HepeX B 61 ganetespib 61 Fx #A 61 Ron Bentsur 61 LEVADEX TM 61 Alfacell 61 Amplimexon 61 FACTIVE tablets 61 TYZEKA 61 Tavocept 61 Cellgate Inc. 61 Gastrotech 61 IDM Pharma 61 Plexxikon 61 Welichem 61 Firazyr 61 Pronova 61 Alocrest 61 ChemGenex Pharmaceuticals Limited 61 DPX Survivac 61 BioMS Medical 61 Tanespimycin 61 Galenea 61 Advitech 61 QRxPharma 61 tafamidis 61 CAMPATH 61 metastatic hormone refractory 61 Flutiform TM 61 vosaroxin 61 Tarvacin TM 61 Can Fite 61 CEQ# 61 Tesmilifene 61 Phase Ib clinical 61 TOCOSOL Paclitaxel 61 RhuDex TM 61 Cytochroma 61 Oncolin 61 AeroLEF TM 61 SWX SPPN 61 cannabinor 61 Alpharadin 61 J. Mazzo Ph.D. 61 reslizumab 61 Jennerex 61 Cethrin 61 ZEFTERA TM Zevtera TM 61 ONCASPAR 61 Innate Pharma 61 BioXell 61 Phase Ib II 61 Prednisporin 61 MacroMed 61 Bendamustine 61 OTCBB PYTO FWB ET6 60 Alvesco R 60 Transave 60 Phase III randomized controlled 60 TEMODAL 60 CRD5 60 Nventa 60 pexiganan 60 RHEI Pharmaceuticals 60 liposomal formulation 60 BioInvent International 60 Azixa 60 Velcade bortezomib 60 AMEX DDD 60 ImmunoCellular Therapeutics 60 Announcement acc 60 NeuVax 60 OMP #M# 60 CardioVascular BioTherapeutics Inc. 60 Anaphore 60 OvaRex R 60 NYSE Amex PTN 60 NVA# 60 NattoPharma 60 SUTENT ® 60 NP2 Enkephalin 60 Viventia 60 Surfaxin LS 60 Novelos 60 YONDELIS R 60 Zingo TM 60 mSEPT9 biomarker 60 ospemifene 60 Generx ™ 60 Cannasat 60 BiTE antibody 60 indibulin 60 Sebivo 60 Quinamed 60 PEG SN# 60 Timo Veromaa 60 Rapinyl 60 Addex 60 Increlex R 60 Arpida 60 Epiphany Biosciences 60 STO SOBI 60 Tostrex 60 AMEX RGN 60 Protox 60 NeuroSolutions 60 Astex Therapeutics 60 ALD# 60 Mipomersen 60 ZARS Pharma 60 forodesine 60 Cardio Vascu Grow 60 Janssen Pharmaceutica NV 60 Aurexis 60 Pharnext 60 Procyon Biopharma 60 THR beta agonist 60 Creabilis Therapeutics 60 Actemra tocilizumab 60 DDP# 60 Karolinska Development 60 Bortezomib 60 Biotie Therapies 60 PRNewswire FirstCall OncoGenex Pharmaceuticals 60 RAPTIVA R 60 Phase IIa clinical trials 60 talactoferrin 60 Gemin X 60 ThermoDox ® 60 OncoMethylome 60 Diatos 60 Urodynamix 60 Nasdaq ENZN 60 OncoGenex Technologies 60 Debiopharm Group 60 Juergen Engel Ph.D. 60 Resverlogix Corp. Resverlogix 60 Aradigm Corporation 60 Nitec Pharma 60 YM Biosciences 60 ELND# 60 Celladon Corporation 60 E1 INT TM 60 rALLy clinical trial 60 Dacogen injection 60 Ulrich Dauer CEO 60 Endovasc 60 cinacalcet HCl 60 tramiprosate ALZHEMED TM 60 Nanobody R 60 Phase IIB 60 PRNewswire FirstCall YM BioSciences 60 ViRexx 60 Christian Melen 60 Myrexis Inc. 60 pitavastatin 60 Cellzome 60 SEBIVO 60 Evotec AG 60 NeuroMedix 60 Nippon Shinyaku 60 Bayer HealthCare AG 60 proteasome inhibitor 60 Inc. AMEX YMI 60 BioWa 60 Photocure ASA 60 WILEX AG 60 Alseres 60 Nuvion 60 Gendux 60 pralatrexate 60 FluoroPharma 60 Kirsten Drejer 60 huC# DM4 60 Targeted Chemotherapy 60 Tolerx 60 OGeS 60 INCB# [002] 60 Neurobiological Technologies 60 GRNVAC1 60 Raptiva R 60 Antisense Pharma 60 Corcept 60 pomalidomide 60 MEPACT 60 ProtAffin 60 Astex 60 ASA# 60 Hedgehog antagonist 60 PANVAC VF 60 BiTE R 60 Insegia 60 Civacir 60 CD# CEA 60 Kineret R 60 Biovitrum AB 60 Aryplase 60 herpetic keratitis 60 Oncolys 60 Phenoptin 60 Argatroban 60 vascular disrupting agent 60 Ceragenix 60 investigational humanized monoclonal antibody 60 MyVax ® 60 vascular disrupting agents 60 GlaxoSmithKline plc GSK 60 Aplidin R 60 Per Olof Wallström 60 Tarvacin 60 IV Busulfex 60 volociximab 60 OTCBB HXBM developer 60 LIVALO 60 ESBATech 60 Ardea Biosciences 60 Triolex 60 Chromos 60 Marketing Authorisation Application 60 Mycamine 60 pediatric acute lymphoblastic 60 BAY #-# 60 TAFA# 60 SIR Spheres 60 relapsed leukemia 60 Debio 60 ImmunoCellular 60 MORAb 60 Nexavar sorafenib 60 BioPhausia 60 CRLX# 60 Affibody AB 60 Akela Pharma Inc. 60 MKC# MKC# PP 60 GLASSIA 60 Metabasis Therapeutics 60 NASDAQ IPXL today 60 Apaziquone 60 KNS # 60 Spirogen 60 prostone 60 Pharmalink 60 Pertuzumab 60 ORTHOCON 60 Oglemilast 60 AZILECT ® 60 PDE# inhibitors 60 Juvantia 60 otelixizumab 60 Verisante 60 OncoGenex 60 Orphan Therapeutics 60 Portola Pharmaceuticals 60 BioAxone 60 DiaGenic ASA 60 CoTherix Inc. 60 IND submission 60 MediCult 60 Panzem 60 Loic Maurel 60 Avila Therapeutics 60 Golimumab 60 Avidex 60 molecular imaging radiopharmaceutical 60 Arpida Ltd. 60 Loramyc TM 60 thalidomide Thalomid 60 BioDelivery Sciences 60 Zentaris 60 Fodosine 60 liprotamase 60 Viramidine 60 MIGENIX 60 NASDAQ DYAX 60 tramiprosate Alzhemed TM 60 Biovitrum AB publ 60 Somatuline R Autogel R 60 Dr. Damaj 60 Xerese 60 MBP# [001] 59 sunitinib malate 59 orphan designation 59 danoprevir 59 JP-#/fipamezole 59 LUCASSIN 59 valopicitabine 59 belinostat 59 candidate epratuzumab 59 TREANDA 59 Sidec 59 Gentamicin Surgical Implant 59 Bioheart Inc. 59 ONTAK 59 PNT# 59 Calistoga Pharmaceuticals 59 targeting CD# 59 Tacere 59 PAION AG 59 Synosia 59 lumiliximab 59 Cempra 59 CD3 monoclonal antibody 59 Nymox Pharmaceutical Corporation 59 eprodisate KIACTA TM 59 SEQUENOM 59 Adventrx 59 FermaVir 59 Sanofi aventis EURONEXT SAN 59 pertuzumab 59 TESARO 59 OncoVEX 59 Onco TCS 59 Migenix 59 Sanochemia 59 Aloxi R 59 NASDAQ ARRY 59 HuMax TAC 59 Ventavis 59 Regado Biosciences 59 Addrenex 59 Telatinib 59 Phase #b/#a clinical 59 elinogrel 59 Metaphore 59 Fujisawa Healthcare Inc. 59 OTCBB PYTO 59 Revlimid lenalidomide 59 Androxal TM 59 Anacor 59 allosteric modulation 59 dasatinib Sprycel ® 59 Sven Andreasson 59 BioSeek 59 Lytix Biopharma 59 Endotis Pharma 59 omacetaxine mepesuccinate 59 MultiCell Technologies 59 Nasdaq VRTX 59 ONCONASE 59 Nasdaq MBRX announced 59 silodosin 59 oral fludarabine 59 Zosano 59 PhytoMedical 59 NASDAQ AVEO 59 Degarelix 59 PROMACTA 59 phase IIa 59 KemPharm 59 drug conjugate 59 bazedoxifene 59 Aerovance 59 Veronate 59 ERYtech Pharma 59 EpiTherapeutics 59 Isotechnika Pharma 59 DeveloGen 59 REGENERX BIOPHARMACEUTICALS INC. 59 MAP Pharmaceuticals 59 Lodotra 59 PSMA ADC 59 Neuradiab 59 Cellegy 59 MOLOGEN 59 FRDA 59 Virulizin 59 Movetis 59 Evoltra ® 59 Debiopharm SA 59 NASDAQ LGND 59 ENZON 59 Shigamabs ® 59 Phase 2a clinical trials 59 Jerini AG 59 mifamurtide 59 Navamedic ASA 59 inhaled formulation 59 L BLP# 59 dermatology biopharmaceutical company 59 JenaValve 59 Arqule 59 Yondelis ® 59 CCX# B 59 Angioblast 59 Eligard ® 59 Oncothyreon 59 Rescula 59 faropenem 59 Phase III psoriasis 59 daclizumab 59 Oxford BioMedica 59 OncoVEX GM CSF 59 OTCBB CVBT 59 RH1 59 preclinically 59 Lumacan 59 triphendiol 59 Celsion Corporation 59 Regeneron Pharma 59 GSK '# 59 CCR9 antagonist 59 Cimzia TM 59 AVASTIN 59 Affimed 59 SYN# 59 RSD# oral 59 Liprostin 59 Galderma SA 59 bluebird bio 59 R roscovitine 59 NASDAQ CXSP announced 59 Oxxon 59 Oracea ® 59 Lung Rx 59 PRTX 59 SCHWARZ PHARMA 59 YM BioSciences 59 FOLOTYN 59 Tamibarotene 59 novel VDA molecule 59 Albugon 59 Relivar 59 TKM ApoB 59 SynCo Bio Partners 59 photoprotective drug 59 Ceflatonin R 59 Nasdaq PGNX today 59 BLP# Liposome Vaccine 59 Xyrem ® 59 HspE7 59 FoldRx Pharmaceuticals Inc. 59 Affibody 59 Syncria 59 ACLARA 59 SR Pharma 59 Canvaxin 59 Innodia 59 Phase IIa clinical 59 VALSTAR 59 inhaled AAT 59 Speedel 59 Vantia Therapeutics 59 TRISENOX 59 CorMedix 59 Nippon Kayaku 59 Multiferon R 59 Trubion Pharma 59 Diamyd Medical AB 59 RLY# 59 Tarmogen 59 tesmilifene 59 NASDAQ FLML 59 veltuzumab 59 Fentanyl Taifun 59 Theratope 59 Nexavar ® 59 IMiDs ® compound 59 XYOTAX TM 59 Bayer Schering Pharma 59 Barry D. Quart 59 octreotide implant 59 DCVax R 59 ZEVALIN ® 59 Metvix 59 StromaCel Inc. 59 VIRxSYS 59 AVN# [001] 59 CyDex Pharmaceuticals Inc. 59 ASONEP 59 Dapagliflozin 59 Ipsen SA 59 Vernakalant 59 IMC #B 59 vorinostat 59 EndoTAG TM 59 oral taxane 59 Active Biotech NASDAQ OMX 59 MAXY alpha 59 MAP# 59 SOBI 59 IMiD 59 myeloproliferative disorders 59 G#DT 59 Emisphere Technologies 59 Zoraxel 59 Irinotecan 59 Unit Dose Budesonide 59 AVONEX ® 59 StemEx R 59 CCX# 59 Phase 2b study 59 Indaflex TM 59 clofarabine 59 Alemtuzumab 59 alemtuzumab Campath 59 Borean Pharma 59 Elafin 59 Metabasis Therapeutics Inc. 59 Steven B. Ratoff 59 tivozanib 59 efalizumab 59 OHR/AVR# 59 Lovaza TM 59 sapacitabine 59 Idenix 59 Firdapse 59 Azilect ® 59 oral dual endothelin 59 thetreatment 59 HuMax HepC TM 59 ATG Fresenius S 59 OTCBB UGNE http:/www.unigene.com 59 ezogabine 59 Dermylex TM 59 TACI Ig 59 incyclinide 59 JAK inhibitors 59 Symadex 59 PDX pralatrexate 59 therapeutic monoclonal antibodies 59 Vaccinogen 59 Mitchel Sayare 59 Phase IIa trial 59 Somatuline Depot 59 Akesis 59 Graffinity Pharmaceuticals 59 Alexis Borisy President 59 SpePharm 59 EchoCRT 59 Eligard R 59 Marqibo TM 59 anti CD3 monoclonal 59 Vitrolife 59 Yves Rosconi President 59 albinterferon alfa 2b 59 ProLindac 59 LEAD Therapeutics 59 STO BVT 59 Pervasis 59 amrubicin 59 Sigma Tau SpA 59 initiate Phase 1b 59 Exelixis compounds 59 Senetek 59 CA9 SCAN 59 3SBio 59 Ortec 59 Logical Therapeutics 59 Archemix 59 Angiocept 59 relapsed multiple myeloma 59 EvoGenix 59 ALN TTR# 59 histone deacetylase HDAC inhibitor 59 OncoSec 59 Plenaxis R 59 Medistem Laboratories 59 Rebif ® 59 TargeGen 59 KRN# 59 casopitant 59 Medivir 59 Ampio 59 photodisinfection 59 Trofex TM 59 Curon Medical 59 MEK inhibitor 59 ImmuneRegen BioSciences Inc. 59 BioCancell 59 KIACTA ™ 59 Harry Palmin President 59 Elagolix 59 UVIDEM 59 HCD# [002] 59 ANG# 59 PEP# [003] 59 AVEO 59 Clinuvel 58 Phase IIa trials 58 Cloretazine 58 Ambrx 58 ACOMPLIA R 58 ISIS # 58 SinuNase TM 58 Aegera Therapeutics Inc. 58 ITAX 58 Trofex 58 HCV protease inhibitor 58 Exherin 58 ARIUS 58 NASDAQ ABII 58 Ofatumumab 58 Peregrine Pharmaceuticals 58 investigational monoclonal antibody 58 Pradefovir 58 Zorbtive TM 58 Phase IIb clinical trials 58 StemEx 58 Santhera Pharmaceuticals 58 2 inhibitor CYT# 58 CeNeRx BioPharma 58 Celmed 58 SMT C# 58 Ascenta 58 Actelion Ltd 58 HuCAL antibodies 58 PEGylated Fab fragment 58 BioMS 58 TSX ONY 58 Biopartners 58 romiplostim 58 lintuzumab 58 DAIICHI SANKYO 58 Genaera Corporation 58 Swedish Orphan 58 InfaCare 58 Affimed Therapeutics AG 58 Sosei

Back to home page